Dental Implants and Osteoporosis Medicines: What to Tell Your Dentist Before Treatment

Osteoporosis medicines do not automatically rule out implants. Learn what the evidence says and which medication details to share before treatment.
3D imaging
Comprehensive implant dentistry by an experienced & trusted team

Taking an osteoporosis medicine does not automatically rule out dental implants, but it is something your dentist needs to know before planning treatment. Antiresorptive drugs, such as bisphosphonates (for example alendronate, sold as Fosamax) and denosumab (Prolia), slow the breakdown of bone and are linked to a rare jaw complication. The decision depends on the drug, the dose, how long you have taken it and your overall health, so it is made individually and, when needed, together with the clinician who prescribes your medicine.

Why These Medicines Matter for Implant Planning

An implant has to bond with the jawbone, and antiresorptive medicines change how bone is broken down and renewed. The American Dental Association's overview of osteoporosis medications and MRONJ explains that these drugs are uncommonly linked to a significant complication, medication-related jaw osteonecrosis, usually shortened to MRONJ. With MRONJ, a patch of jawbone becomes exposed and fails to heal. Tooth removal and similar surgery can set it off, yet it sometimes appears in people who have had no recent dental work.

Osteoporosis treatment and high-dose cancer treatment should not be treated as the same situation. Antiresorptive medicines given at the higher doses and more frequent intervals used for certain cancers carry a substantially greater risk of MRONJ. For osteoporosis-dose treatment, this complication is uncommon, and the ADA emphasizes the importance of protecting patients from fractures.

For example, Prolia and Xgeva both contain denosumab, but they are used with different dosing schedules and indications. The drug name alone is not enough to assess risk. Your dentist needs to know the dose, schedule and reason for treatment, because those details can change whether implant surgery is appropriate.

What the Current Evidence Says About Implants

According to the expert recommendations the ADA summarizes, osteoporosis-dose antiresorptive treatment does not automatically exclude a patient from receiving an implant. The ADA is careful to add that the research is still limited: researchers still want bigger studies that follow patients for longer before they can confirm whether implants last as well in people on these drugs as in people who never used them.

In plain terms, many people taking these medicines may still be candidates, but the evidence is not strong enough for a blanket answer. Your dentist weighs your details against that uncertainty.

This does not mean the same recommendation applies to high-dose cancer regimens. Implant placement is generally avoided during high-dose antiresorptive treatment for cancer. Patients in that situation need a coordinated assessment involving their cancer care team and dental clinician, with other tooth-replacement options considered when appropriate.

Details to Bring to Your Implant Consultation

A complete medication history makes the conversation far more useful. Before an implant consultation, gather:

Detail Why it helps
Drug name and form (pill, yearly infusion, injection every few months) The ADA notes risk varies with drug, dose and treatment schedule
Why it was prescribed (osteoporosis prevention or treatment versus a cancer-related use) The ADA notes cancer-related dosing carries higher risk
How long you have taken it, and any past osteoporosis drugs The ADA links longer treatment, beyond roughly two years, to higher risk
Date of your last dose or injection Helps your dental team and prescriber coordinate timing
Steroids, diabetes and gum disease history The ADA lists these among MRONJ risk factors
Prescriber's name and contact information Makes coordination straightforward if your dentist wants to consult

On smaller screens, scroll the table sideways to see every column.

Why You Should Not Change Your Medicine on Your Own

It can be tempting to skip a dose or delay an injection before dental work. That decision belongs to the clinician managing your bone health, not to you alone or to your dental office. The ADA notes that stopping bisphosphonates may not remove the MRONJ risk and may harm the outcome of osteoporosis treatment. Bring your questions to both your dentist and your prescriber, and let them decide together.

If you take Prolia (denosumab), never delay, skip or discontinue treatment without coordinating with your prescribing physician. Interrupting Prolia can increase fracture risk, including fractures in the spine. Any change to injection timing or a switch to another medicine must be planned by the prescriber in consultation with the dental team. Prolia safety information

How Your Dentist Assesses the Jaw

At Ashland Family and Implant Dentistry, Dr. Ali Almaawi, DDS, FICOI plans, places and restores dental implants in-house. This continuity helps the team consider your medical history alongside the condition of your teeth, gums and jawbone. Ashland Family and Implant Dentistry describes using 3D CBCT imaging when indicated to evaluate bone for treatment planning. Imaging shows bone volume and anatomy; it does not on its own predict your MRONJ risk. That assessment comes from combining the scan, your gum health and your medication history.

The ADA also emphasizes prevention: for people on these medicines, keeping the mouth healthy day to day and seeing the dentist routinely may be the best approach to reducing the chance of MRONJ. Treating gum disease or infected teeth early, and keeping up with checkups, supports both your natural teeth and any future implant.

Frequently Asked Questions

Do all osteoporosis medicines carry this jaw risk?

No. According to the ADA, some other osteoporosis treatments, such as raloxifene, calcitonin, teriparatide or abaloparatide, do not share the MRONJ risk tied to bisphosphonates, to denosumab and to romosozumab (Evenity). That is why the exact drug name matters.

Do vitamin D and calcium supplements count?

They are not the antiresorptive drugs linked to MRONJ in the ADA's summary. List them anyway, because a complete record helps your dentist understand your bone health treatment as a whole.

I stopped taking Fosamax years ago. Does it still matter?

Mention it. The ADA lists prolonged use of antiresorptive drugs among MRONJ risk factors, so your past treatment history is relevant, not only your current prescriptions. Your dentist, and if needed your prescriber, will decide how much weight it carries for you.

What does osteonecrosis of the jaw look or feel like?

The ADA explains that it shows up as bone visible through the gum, usually painful and often draining, although some people have no symptoms. If you notice exposed bone or a sore that does not heal after dental work, contact your dentist promptly.

Can a removable denture be an alternative if implants are not advised?

Your dentist can discuss other tooth replacement options if implants are not the right fit. The ADA lists denture use among the factors that can influence MRONJ risk, so a well-fitting appliance and regular follow-up still matter.

Planning Implant Treatment With Your Full Health Picture

If you take an osteoporosis medicine and are wondering whether implants could work for you, schedule a consultation with Ashland Family and Implant Dentistry and bring your medication details. You can view the practice on Google for directions or call 508-881-7700.

Facebook
Twitter
Email
LinkedIn
Pinterest
WhatsApp
Questions? Get In Touch!
Browse Further